Renoprotective Effects of DPP-4 Inhibitors

Kawanami, D; Takashi, Y; Takahashi, H; Motonaga, R; Tanabe, M

Kawanami, D (corresponding author), Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Fukuoka 8140180, Japan.

ANTIOXIDANTS, 2021; 10 (2):

Abstract

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely use......

Full Text Link